Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
2023-06-30 20:47
Ex-Pfizer Employee Charged With Illegal Trades on Paxlovid Trial
A former Pfizer Inc. employee was charged with using inside information about the company’s Covid-19 treatment Paxlovid to
2023-06-30 02:23
Ipsen Gets FDA Advisers’ Backing for Rare Bone Disease Drug
Ipsen SA’s drug for a rare bone disease got support from a panel of US drug regulatory advisers,
2023-06-29 15:25
Pfizer Drops as Obesity Drug Halted on Safety Concerns
Pfizer Inc. shares fell after it halted early development of an oral drug for weight loss on safety
2023-06-27 01:45
Covid-19 Origins Remain a Mystery, Declassified Report Shows
US intelligence agencies weren’t able to determine whether researchers at laboratory in Wuhan, China, who fell sick in
2023-06-24 09:46
Eli Lilly’s Experimental Weight-Loss Pill Show Rapid Results in Study
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the
2023-06-24 05:54
Pfizer, GSK Shots for RSV Get Backing for Older Adults
Shots from Pfizer Inc. and GSK Plc that prevent respiratory syncytial virus received backing from a panel of
2023-06-22 08:54
Carson Block’s Latest Short Bet Is Burned by Novartis M&A Deal
Carson Block’s Muddy Waters wager against a hedge-fund favorite, Chinook Therapeutics Inc., took a hit Monday after Novartis
2023-06-12 23:48
Illumina CEO DeSouza Resigns After Facing Pressure From Icahn
Illumina Inc.’s board accepted the resignation of Chief Executive Officer Francis deSouza, effective Sunday, according to a statement.
2023-06-11 20:54
Merck Sues US, Calling Move to Cut Drug Prices ‘Extortion’
Merck & Co. is suing the US over a law that will allow the government to negotiate prescription-drug
2023-06-07 01:58
Waste-Treatment Mess Spawns Cholera in South Africa Capital
Dysfunctional waste-water treatment around the South African capital of Pretoria contributed to a deadly cholera outbreak that’s left
2023-05-23 00:58
Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify
Teva Pharmaceutical Industries Ltd. plans to cut back manufacturing of generic drugs, citing low profitability, at a time
2023-05-19 05:29